Clinical Trials Sponsored by Alan Fujii

Total 1234 results

1
2
3
4
5
6
7
8
9
10
...
24
25
›

Alan Fujii
Dey LP

Terminated

Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants (CAST)

Respiratory Distress Syndrome | Patent Ductus Arteriosus | Prematurity

United States
Fuji Yakuhin Co., Ltd.

Completed

Repeated Dose Phase I Study of FYU-981

Healthy

Japan
Shoichi Fujii, MD, PhD

Unknown

Randomized Controlled Trial Between Laparoscopic and Open Surgery in Transverse and Descending Colon Cancer Patients

Malignant Neoplasm of Transverse Colon | Malignant Neoplasm of Descending Colon

Japan
Shoichi Fujii, MD, PhD

Unknown

Trial to Evaluate Laparoscopic Versus Open Surgery in Elderly Colorectal Cancer Patients

Colorectal Cancer

Japan
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)

Hyperuricemia

Japan
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

Healthy

Japan
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)

Healthy | Renal Insufficiency

Japan
Fuji Yakuhin Co., Ltd.

Completed

Single Dose Phase I Study of FYU-981

Healthy

Japan
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Elder Subjects)

Healthy

Japan
Fuji Systems Corporation
Avania

Active, not recruiting

Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair

Aortic Aneurysm | Aortic Dissection | Aortic Arch Aneurysm | Aortic Arch; Aneurysm, Dissecting

Germany, Netherlands
Fuji Yakuhin Co., Ltd.

Completed

Study of FFI-1010 in Pediatric Kidney Disease

Children Under 18 Years Old With Kidney Disease

Japan
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia

Japan
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia

Japan
Shoichi Fujii, MD, PhD

Unknown

Randomized Controlled Trial to Evaluate High Tie Versus Low Tie of the Inferior Mesenteric Artery in Anterior Resection

Rectal Cancer | Colon Rectal Resection

Japan
Robin, Alan L., M.D.

Completed

IOP Changes Associated With SICS and Phako

Glaucoma | Cataract
Robin, Alan L., M.D.

Completed

Impact of Health Literacy and Other Factors on Glaucoma Patient Adherence in South India

Glaucoma | Health Literacy | Patient Noncompliance

India
Robin, Alan L., M.D.

Terminated

An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation

Ocular Hypertension | Glaucoma

United States
Alan Neuromedical Technologies, LLC

Completed

Duchenne Muscular Dystrophy Clinical Trial (DMD)

Duchenne Muscular Dystrophy

United States
Robin, Alan L., M.D.

Completed

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

Ocular Hypertension | Glaucoma
KGK Science Inc.
Fuji Oil Co. Ltd.

Completed

Investigating the Effects of Glucodia™ on Glucose Parameters, Triglycerides and Body Weight (14GGHF)

Body Weight | Triglycerides | Glucose Parameters

Canada
Stanford University
Schatzberg, Alan, M.D.

Completed

Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression: OL Cohort (SAINT-TRD)

Treatment Resistant Depression

United States
Alan Katz

Completed

Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma

Liver Neoplasms

United States
alan apter

Completed

A Clinical Research Studying Interventions for Nighttime Fears in Preschool Children

Nighttime Fears

Israel
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

Hyperuricemia With or Without Gout

Japan
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Mass Balance Study of FYU-981

Healthy Male Subjects

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Final Formulation)

Healthy

Japan
Loyola University
Alan J. Wolfe

Completed

Bladder Environment: Microbiome Oxygen Relationship (BEMOR)

Urinary Incontinence | UTI's

United States
Alan Katz

Withdrawn

Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

Pancreas Cancer | Adenocarcinoma of the Pancreas

United States
Stanford University
Schatzberg, Alan, M.D.

Completed

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) (Ket_Nal)

Depression

United States
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

Hepatic Insufficiency | Healthy

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Drug-drug Interaction Study of FYU-981 and Oxaprozin

Healthy

Japan
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Dr. Bruce B. Allan

Completed

Study of Non-Ablative Radiofrequency Treatment for Stress Urinary Incontinence

Stress Urinary Incontinence

Canada
ASLAN Pharmaceuticals

Recruiting

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

Atopic Dermatitis

United States, Canada
ASLAN Pharmaceuticals

Completed

A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumors | Advanced or Metastatic Biliary Tract Cancer

Japan
ASLAN Pharmaceuticals

Withdrawn

Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer

Advanced or Metastatic Biliary Tract Cancer
ASLAN Pharmaceuticals

Completed

Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003

Healthy Volunteers

Singapore
Elan Pharmaceuticals

Completed

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

Pain

United States
Elan Pharmaceuticals

Terminated

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United States, Canada
Elan Pharmaceuticals

Completed

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

Migraine Headache

United States
Elan Pharmaceuticals

Completed

Prialt (Ziconotide) In Severe Chronic Pain

Pain

United States
Elan Pharmaceuticals

Completed

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

Stroke | Multiple Sclerosis | Muscle Spasticity | Spinal Cord Injury

United States
Elan Pharmaceuticals

Terminated

Open-label Adjunctive Zonisamide for Bipolar Disorder

Bipolar Disorders
Alan Richardson
Quotient Clinical

Terminated

First in Human Single Ascending Dose Study of MOR107

Safety

United Kingdom
Alan Nichol

Completed

Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study

Cancer (High-grace Glioma)

Canada
Robin, Alan L., M.D.
Alcon Research

Unknown

Observational Study of How Patients Take Eye Drops

Glaucoma

United States
ASLAN Pharmaceuticals

Recruiting

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants (FAST-AA)

Alopecia Areata

United States
ASLAN Pharmaceuticals

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis

Atopic Dermatitis

Australia, Singapore, United States

1
2
3
4
5
6
7
8
9
10
...
24
25
›

3

Subscribe